Phase 1 Trials: Are We Using Optimal Drug Dose Schedules? Phase 1 Trials: Are We Using Optimal Drug Dose Schedules?

David J. Kerr, CBE, MD, DSc, discusses considerations for dosing schedules in Phase 1 trials.Medscape Oncology
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news